ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Neurology Clinical Trial Market Research Report 2024
Published Date: July 2024
|
Report Code: QYRE-Auto-32H13810
Home | Market Reports | Health| Health Foundations & Medical Research
Global Neurology Clinical Trial Market Research Report 2023
BUY CHAPTERS

Global Neurology Clinical Trial Market Research Report 2024

Code: QYRE-Auto-32H13810
Report
July 2024
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Brainstorm Cell Therapeutics
Opexa Therapeutics
Caladrius Biosciences
U S Stem Cell
Lonza
Bristol–Myers Squibb
Corning Incorporated
Vericel Corporation
Catalent
Lineage Cell Therapeutics
Castle Creek Biosciences
Sangamo Therapeutics
Novartis
Holostem Terapie Avanzate S.r.l.
PHARMICELL
Autolus Therapeutics
Bayer
Sartorius
Daiichi Sankyo
Takeda Pharmaceutical Company
Sumitomo Chemical Co.
Tego Science

Neurology Clinical Trial Market

The global Neurology Clinical Trial market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Neurology Clinical Trial is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Neurology Clinical Trial is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Neurology Clinical Trial in Neurodegenerative Disorders is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Neurology Clinical Trial include BrainStorm Cell Therapeutics, Opexa Therapeutics, Caladrius Biosciences, U.S. Stem Cell, Lonza, Bristol Myers Squibb, Corning Incorporated, Vericel Corporation and Catalent, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Neurology Clinical Trial, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurology Clinical Trial.

Report Scope

The Neurology Clinical Trial market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neurology Clinical Trial market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurology Clinical Trial companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Neurology Clinical Trial Market Report

Report Metric Details
Report Name Neurology Clinical Trial Market
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company BrainStorm Cell Therapeutics, Opexa Therapeutics, Caladrius Biosciences, U.S. Stem Cell, Lonza, Bristol Myers Squibb, Corning Incorporated, Vericel Corporation, Catalent, Lineage Cell Therapeutics, Castle Creek Biosciences, Sangamo Therapeutics, Novartis, Holostem Terapie Avanzate S.R.L, Pharmicell, Tego Science, Autolus therapeutics, Bayer AG, Sartorius AG, Daiichi Sankyo, Takeda Pharmaceutical Company, Sumitomo Chemical Co
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Neurology Clinical Trial companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Neurology Clinical Trial Market report?

Ans: The main players in the Neurology Clinical Trial Market are BrainStorm Cell Therapeutics, Opexa Therapeutics, Caladrius Biosciences, U.S. Stem Cell, Lonza, Bristol Myers Squibb, Corning Incorporated, Vericel Corporation, Catalent, Lineage Cell Therapeutics, Castle Creek Biosciences, Sangamo Therapeutics, Novartis, Holostem Terapie Avanzate S.R.L, Pharmicell, Tego Science, Autolus therapeutics, Bayer AG, Sartorius AG, Daiichi Sankyo, Takeda Pharmaceutical Company, Sumitomo Chemical Co

What are the Application segmentation covered in the Neurology Clinical Trial Market report?

Ans: The Applications covered in the Neurology Clinical Trial Market report are Neurodegenerative Disorders, Cardiovascular Disorders, Orthopedics, Wound Healing, Other

What are the Type segmentation covered in the Neurology Clinical Trial Market report?

Ans: The Types covered in the Neurology Clinical Trial Market report are Bone Marrow, Epidermis, Mesenchymal Stem Cells, Haematopoietic Stem Cells, Chondrocytes

Recommended Reports

Neurodegenerative Diseases

Clinical Trial Services

Neurovascular Devices

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurology Clinical Trial Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Bone Marrow
1.2.3 Epidermis
1.2.4 Mesenchymal Stem Cells
1.2.5 Haematopoietic Stem Cells
1.2.6 Chondrocytes
1.3 Market by Application
1.3.1 Global Neurology Clinical Trial Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Neurodegenerative Disorders
1.3.3 Cardiovascular Disorders
1.3.4 Orthopedics
1.3.5 Wound Healing
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neurology Clinical Trial Market Perspective (2019-2030)
2.2 Neurology Clinical Trial Growth Trends by Region
2.2.1 Global Neurology Clinical Trial Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Neurology Clinical Trial Historic Market Size by Region (2019-2024)
2.2.3 Neurology Clinical Trial Forecasted Market Size by Region (2025-2030)
2.3 Neurology Clinical Trial Market Dynamics
2.3.1 Neurology Clinical Trial Industry Trends
2.3.2 Neurology Clinical Trial Market Drivers
2.3.3 Neurology Clinical Trial Market Challenges
2.3.4 Neurology Clinical Trial Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neurology Clinical Trial Players by Revenue
3.1.1 Global Top Neurology Clinical Trial Players by Revenue (2019-2024)
3.1.2 Global Neurology Clinical Trial Revenue Market Share by Players (2019-2024)
3.2 Global Neurology Clinical Trial Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neurology Clinical Trial Revenue
3.4 Global Neurology Clinical Trial Market Concentration Ratio
3.4.1 Global Neurology Clinical Trial Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neurology Clinical Trial Revenue in 2023
3.5 Neurology Clinical Trial Key Players Head office and Area Served
3.6 Key Players Neurology Clinical Trial Product Solution and Service
3.7 Date of Enter into Neurology Clinical Trial Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neurology Clinical Trial Breakdown Data by Type
4.1 Global Neurology Clinical Trial Historic Market Size by Type (2019-2024)
4.2 Global Neurology Clinical Trial Forecasted Market Size by Type (2025-2030)
5 Neurology Clinical Trial Breakdown Data by Application
5.1 Global Neurology Clinical Trial Historic Market Size by Application (2019-2024)
5.2 Global Neurology Clinical Trial Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Neurology Clinical Trial Market Size (2019-2030)
6.2 North America Neurology Clinical Trial Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Neurology Clinical Trial Market Size by Country (2019-2024)
6.4 North America Neurology Clinical Trial Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neurology Clinical Trial Market Size (2019-2030)
7.2 Europe Neurology Clinical Trial Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Neurology Clinical Trial Market Size by Country (2019-2024)
7.4 Europe Neurology Clinical Trial Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neurology Clinical Trial Market Size (2019-2030)
8.2 Asia-Pacific Neurology Clinical Trial Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Neurology Clinical Trial Market Size by Region (2019-2024)
8.4 Asia-Pacific Neurology Clinical Trial Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neurology Clinical Trial Market Size (2019-2030)
9.2 Latin America Neurology Clinical Trial Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Neurology Clinical Trial Market Size by Country (2019-2024)
9.4 Latin America Neurology Clinical Trial Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neurology Clinical Trial Market Size (2019-2030)
10.2 Middle East & Africa Neurology Clinical Trial Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Neurology Clinical Trial Market Size by Country (2019-2024)
10.4 Middle East & Africa Neurology Clinical Trial Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BrainStorm Cell Therapeutics
11.1.1 BrainStorm Cell Therapeutics Company Detail
11.1.2 BrainStorm Cell Therapeutics Business Overview
11.1.3 BrainStorm Cell Therapeutics Neurology Clinical Trial Introduction
11.1.4 BrainStorm Cell Therapeutics Revenue in Neurology Clinical Trial Business (2019-2024)
11.1.5 BrainStorm Cell Therapeutics Recent Development
11.2 Opexa Therapeutics
11.2.1 Opexa Therapeutics Company Detail
11.2.2 Opexa Therapeutics Business Overview
11.2.3 Opexa Therapeutics Neurology Clinical Trial Introduction
11.2.4 Opexa Therapeutics Revenue in Neurology Clinical Trial Business (2019-2024)
11.2.5 Opexa Therapeutics Recent Development
11.3 Caladrius Biosciences
11.3.1 Caladrius Biosciences Company Detail
11.3.2 Caladrius Biosciences Business Overview
11.3.3 Caladrius Biosciences Neurology Clinical Trial Introduction
11.3.4 Caladrius Biosciences Revenue in Neurology Clinical Trial Business (2019-2024)
11.3.5 Caladrius Biosciences Recent Development
11.4 U.S. Stem Cell
11.4.1 U.S. Stem Cell Company Detail
11.4.2 U.S. Stem Cell Business Overview
11.4.3 U.S. Stem Cell Neurology Clinical Trial Introduction
11.4.4 U.S. Stem Cell Revenue in Neurology Clinical Trial Business (2019-2024)
11.4.5 U.S. Stem Cell Recent Development
11.5 Lonza
11.5.1 Lonza Company Detail
11.5.2 Lonza Business Overview
11.5.3 Lonza Neurology Clinical Trial Introduction
11.5.4 Lonza Revenue in Neurology Clinical Trial Business (2019-2024)
11.5.5 Lonza Recent Development
11.6 Bristol Myers Squibb
11.6.1 Bristol Myers Squibb Company Detail
11.6.2 Bristol Myers Squibb Business Overview
11.6.3 Bristol Myers Squibb Neurology Clinical Trial Introduction
11.6.4 Bristol Myers Squibb Revenue in Neurology Clinical Trial Business (2019-2024)
11.6.5 Bristol Myers Squibb Recent Development
11.7 Corning Incorporated
11.7.1 Corning Incorporated Company Detail
11.7.2 Corning Incorporated Business Overview
11.7.3 Corning Incorporated Neurology Clinical Trial Introduction
11.7.4 Corning Incorporated Revenue in Neurology Clinical Trial Business (2019-2024)
11.7.5 Corning Incorporated Recent Development
11.8 Vericel Corporation
11.8.1 Vericel Corporation Company Detail
11.8.2 Vericel Corporation Business Overview
11.8.3 Vericel Corporation Neurology Clinical Trial Introduction
11.8.4 Vericel Corporation Revenue in Neurology Clinical Trial Business (2019-2024)
11.8.5 Vericel Corporation Recent Development
11.9 Catalent
11.9.1 Catalent Company Detail
11.9.2 Catalent Business Overview
11.9.3 Catalent Neurology Clinical Trial Introduction
11.9.4 Catalent Revenue in Neurology Clinical Trial Business (2019-2024)
11.9.5 Catalent Recent Development
11.10 Lineage Cell Therapeutics
11.10.1 Lineage Cell Therapeutics Company Detail
11.10.2 Lineage Cell Therapeutics Business Overview
11.10.3 Lineage Cell Therapeutics Neurology Clinical Trial Introduction
11.10.4 Lineage Cell Therapeutics Revenue in Neurology Clinical Trial Business (2019-2024)
11.10.5 Lineage Cell Therapeutics Recent Development
11.11 Castle Creek Biosciences
11.11.1 Castle Creek Biosciences Company Detail
11.11.2 Castle Creek Biosciences Business Overview
11.11.3 Castle Creek Biosciences Neurology Clinical Trial Introduction
11.11.4 Castle Creek Biosciences Revenue in Neurology Clinical Trial Business (2019-2024)
11.11.5 Castle Creek Biosciences Recent Development
11.12 Sangamo Therapeutics
11.12.1 Sangamo Therapeutics Company Detail
11.12.2 Sangamo Therapeutics Business Overview
11.12.3 Sangamo Therapeutics Neurology Clinical Trial Introduction
11.12.4 Sangamo Therapeutics Revenue in Neurology Clinical Trial Business (2019-2024)
11.12.5 Sangamo Therapeutics Recent Development
11.13 Novartis
11.13.1 Novartis Company Detail
11.13.2 Novartis Business Overview
11.13.3 Novartis Neurology Clinical Trial Introduction
11.13.4 Novartis Revenue in Neurology Clinical Trial Business (2019-2024)
11.13.5 Novartis Recent Development
11.14 Holostem Terapie Avanzate S.R.L
11.14.1 Holostem Terapie Avanzate S.R.L Company Detail
11.14.2 Holostem Terapie Avanzate S.R.L Business Overview
11.14.3 Holostem Terapie Avanzate S.R.L Neurology Clinical Trial Introduction
11.14.4 Holostem Terapie Avanzate S.R.L Revenue in Neurology Clinical Trial Business (2019-2024)
11.14.5 Holostem Terapie Avanzate S.R.L Recent Development
11.15 Pharmicell
11.15.1 Pharmicell Company Detail
11.15.2 Pharmicell Business Overview
11.15.3 Pharmicell Neurology Clinical Trial Introduction
11.15.4 Pharmicell Revenue in Neurology Clinical Trial Business (2019-2024)
11.15.5 Pharmicell Recent Development
11.16 Tego Science
11.16.1 Tego Science Company Detail
11.16.2 Tego Science Business Overview
11.16.3 Tego Science Neurology Clinical Trial Introduction
11.16.4 Tego Science Revenue in Neurology Clinical Trial Business (2019-2024)
11.16.5 Tego Science Recent Development
11.17 Autolus therapeutics
11.17.1 Autolus therapeutics Company Detail
11.17.2 Autolus therapeutics Business Overview
11.17.3 Autolus therapeutics Neurology Clinical Trial Introduction
11.17.4 Autolus therapeutics Revenue in Neurology Clinical Trial Business (2019-2024)
11.17.5 Autolus therapeutics Recent Development
11.18 Bayer AG
11.18.1 Bayer AG Company Detail
11.18.2 Bayer AG Business Overview
11.18.3 Bayer AG Neurology Clinical Trial Introduction
11.18.4 Bayer AG Revenue in Neurology Clinical Trial Business (2019-2024)
11.18.5 Bayer AG Recent Development
11.19 Sartorius AG
11.19.1 Sartorius AG Company Detail
11.19.2 Sartorius AG Business Overview
11.19.3 Sartorius AG Neurology Clinical Trial Introduction
11.19.4 Sartorius AG Revenue in Neurology Clinical Trial Business (2019-2024)
11.19.5 Sartorius AG Recent Development
11.20 Daiichi Sankyo
11.20.1 Daiichi Sankyo Company Detail
11.20.2 Daiichi Sankyo Business Overview
11.20.3 Daiichi Sankyo Neurology Clinical Trial Introduction
11.20.4 Daiichi Sankyo Revenue in Neurology Clinical Trial Business (2019-2024)
11.20.5 Daiichi Sankyo Recent Development
11.21 Takeda Pharmaceutical Company
11.21.1 Takeda Pharmaceutical Company Company Detail
11.21.2 Takeda Pharmaceutical Company Business Overview
11.21.3 Takeda Pharmaceutical Company Neurology Clinical Trial Introduction
11.21.4 Takeda Pharmaceutical Company Revenue in Neurology Clinical Trial Business (2019-2024)
11.21.5 Takeda Pharmaceutical Company Recent Development
11.22 Sumitomo Chemical Co
11.22.1 Sumitomo Chemical Co Company Detail
11.22.2 Sumitomo Chemical Co Business Overview
11.22.3 Sumitomo Chemical Co Neurology Clinical Trial Introduction
11.22.4 Sumitomo Chemical Co Revenue in Neurology Clinical Trial Business (2019-2024)
11.22.5 Sumitomo Chemical Co Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Brainstorm Cell Therapeutics
Opexa Therapeutics
Caladrius Biosciences
U S Stem Cell
Lonza
Bristol–Myers Squibb
Corning Incorporated
Vericel Corporation
Catalent
Lineage Cell Therapeutics
Castle Creek Biosciences
Sangamo Therapeutics
Novartis
Holostem Terapie Avanzate S.r.l.
PHARMICELL
Autolus Therapeutics
Bayer
Sartorius
Daiichi Sankyo
Takeda Pharmaceutical Company
Sumitomo Chemical Co.
Tego Science
List of Tables
    Table 1. Global Neurology Clinical Trial Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Bone Marrow
    Table 3. Key Players of Epidermis
    Table 4. Key Players of Mesenchymal Stem Cells
    Table 5. Key Players of Haematopoietic Stem Cells
    Table 6. Key Players of Chondrocytes
    Table 7. Global Neurology Clinical Trial Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Neurology Clinical Trial Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Neurology Clinical Trial Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Neurology Clinical Trial Market Share by Region (2019-2024)
    Table 11. Global Neurology Clinical Trial Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Neurology Clinical Trial Market Share by Region (2025-2030)
    Table 13. Neurology Clinical Trial Market Trends
    Table 14. Neurology Clinical Trial Market Drivers
    Table 15. Neurology Clinical Trial Market Challenges
    Table 16. Neurology Clinical Trial Market Restraints
    Table 17. Global Neurology Clinical Trial Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Neurology Clinical Trial Market Share by Players (2019-2024)
    Table 19. Global Top Neurology Clinical Trial Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurology Clinical Trial as of 2023)
    Table 20. Ranking of Global Top Neurology Clinical Trial Companies by Revenue (US$ Million) in 2023
    Table 21. Global 5 Largest Players Market Share by Neurology Clinical Trial Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Neurology Clinical Trial Product Solution and Service
    Table 24. Date of Enter into Neurology Clinical Trial Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Neurology Clinical Trial Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Neurology Clinical Trial Revenue Market Share by Type (2019-2024)
    Table 28. Global Neurology Clinical Trial Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Neurology Clinical Trial Revenue Market Share by Type (2025-2030)
    Table 30. Global Neurology Clinical Trial Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global Neurology Clinical Trial Revenue Market Share by Application (2019-2024)
    Table 32. Global Neurology Clinical Trial Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global Neurology Clinical Trial Revenue Market Share by Application (2025-2030)
    Table 34. North America Neurology Clinical Trial Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. North America Neurology Clinical Trial Market Size by Country (2019-2024) & (US$ Million)
    Table 36. North America Neurology Clinical Trial Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Europe Neurology Clinical Trial Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Europe Neurology Clinical Trial Market Size by Country (2019-2024) & (US$ Million)
    Table 39. Europe Neurology Clinical Trial Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Asia-Pacific Neurology Clinical Trial Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Asia-Pacific Neurology Clinical Trial Market Size by Region (2019-2024) & (US$ Million)
    Table 42. Asia-Pacific Neurology Clinical Trial Market Size by Region (2025-2030) & (US$ Million)
    Table 43. Latin America Neurology Clinical Trial Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Latin America Neurology Clinical Trial Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Latin America Neurology Clinical Trial Market Size by Country (2025-2030) & (US$ Million)
    Table 46. Middle East & Africa Neurology Clinical Trial Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 47. Middle East & Africa Neurology Clinical Trial Market Size by Country (2019-2024) & (US$ Million)
    Table 48. Middle East & Africa Neurology Clinical Trial Market Size by Country (2025-2030) & (US$ Million)
    Table 49. BrainStorm Cell Therapeutics Company Detail
    Table 50. BrainStorm Cell Therapeutics Business Overview
    Table 51. BrainStorm Cell Therapeutics Neurology Clinical Trial Product
    Table 52. BrainStorm Cell Therapeutics Revenue in Neurology Clinical Trial Business (2019-2024) & (US$ Million)
    Table 53. BrainStorm Cell Therapeutics Recent Development
    Table 54. Opexa Therapeutics Company Detail
    Table 55. Opexa Therapeutics Business Overview
    Table 56. Opexa Therapeutics Neurology Clinical Trial Product
    Table 57. Opexa Therapeutics Revenue in Neurology Clinical Trial Business (2019-2024) & (US$ Million)
    Table 58. Opexa Therapeutics Recent Development
    Table 59. Caladrius Biosciences Company Detail
    Table 60. Caladrius Biosciences Business Overview
    Table 61. Caladrius Biosciences Neurology Clinical Trial Product
    Table 62. Caladrius Biosciences Revenue in Neurology Clinical Trial Business (2019-2024) & (US$ Million)
    Table 63. Caladrius Biosciences Recent Development
    Table 64. U.S. Stem Cell Company Detail
    Table 65. U.S. Stem Cell Business Overview
    Table 66. U.S. Stem Cell Neurology Clinical Trial Product
    Table 67. U.S. Stem Cell Revenue in Neurology Clinical Trial Business (2019-2024) & (US$ Million)
    Table 68. U.S. Stem Cell Recent Development
    Table 69. Lonza Company Detail
    Table 70. Lonza Business Overview
    Table 71. Lonza Neurology Clinical Trial Product
    Table 72. Lonza Revenue in Neurology Clinical Trial Business (2019-2024) & (US$ Million)
    Table 73. Lonza Recent Development
    Table 74. Bristol Myers Squibb Company Detail
    Table 75. Bristol Myers Squibb Business Overview
    Table 76. Bristol Myers Squibb Neurology Clinical Trial Product
    Table 77. Bristol Myers Squibb Revenue in Neurology Clinical Trial Business (2019-2024) & (US$ Million)
    Table 78. Bristol Myers Squibb Recent Development
    Table 79. Corning Incorporated Company Detail
    Table 80. Corning Incorporated Business Overview
    Table 81. Corning Incorporated Neurology Clinical Trial Product
    Table 82. Corning Incorporated Revenue in Neurology Clinical Trial Business (2019-2024) & (US$ Million)
    Table 83. Corning Incorporated Recent Development
    Table 84. Vericel Corporation Company Detail
    Table 85. Vericel Corporation Business Overview
    Table 86. Vericel Corporation Neurology Clinical Trial Product
    Table 87. Vericel Corporation Revenue in Neurology Clinical Trial Business (2019-2024) & (US$ Million)
    Table 88. Vericel Corporation Recent Development
    Table 89. Catalent Company Detail
    Table 90. Catalent Business Overview
    Table 91. Catalent Neurology Clinical Trial Product
    Table 92. Catalent Revenue in Neurology Clinical Trial Business (2019-2024) & (US$ Million)
    Table 93. Catalent Recent Development
    Table 94. Lineage Cell Therapeutics Company Detail
    Table 95. Lineage Cell Therapeutics Business Overview
    Table 96. Lineage Cell Therapeutics Neurology Clinical Trial Product
    Table 97. Lineage Cell Therapeutics Revenue in Neurology Clinical Trial Business (2019-2024) & (US$ Million)
    Table 98. Lineage Cell Therapeutics Recent Development
    Table 99. Castle Creek Biosciences Company Detail
    Table 100. Castle Creek Biosciences Business Overview
    Table 101. Castle Creek Biosciences Neurology Clinical Trial Product
    Table 102. Castle Creek Biosciences Revenue in Neurology Clinical Trial Business (2019-2024) & (US$ Million)
    Table 103. Castle Creek Biosciences Recent Development
    Table 104. Sangamo Therapeutics Company Detail
    Table 105. Sangamo Therapeutics Business Overview
    Table 106. Sangamo Therapeutics Neurology Clinical Trial Product
    Table 107. Sangamo Therapeutics Revenue in Neurology Clinical Trial Business (2019-2024) & (US$ Million)
    Table 108. Sangamo Therapeutics Recent Development
    Table 109. Novartis Company Detail
    Table 110. Novartis Business Overview
    Table 111. Novartis Neurology Clinical Trial Product
    Table 112. Novartis Revenue in Neurology Clinical Trial Business (2019-2024) & (US$ Million)
    Table 113. Novartis Recent Development
    Table 114. Holostem Terapie Avanzate S.R.L Company Detail
    Table 115. Holostem Terapie Avanzate S.R.L Business Overview
    Table 116. Holostem Terapie Avanzate S.R.L Neurology Clinical Trial Product
    Table 117. Holostem Terapie Avanzate S.R.L Revenue in Neurology Clinical Trial Business (2019-2024) & (US$ Million)
    Table 118. Holostem Terapie Avanzate S.R.L Recent Development
    Table 119. Pharmicell Company Detail
    Table 120. Pharmicell Business Overview
    Table 121. Pharmicell Neurology Clinical Trial Product
    Table 122. Pharmicell Revenue in Neurology Clinical Trial Business (2019-2024) & (US$ Million)
    Table 123. Pharmicell Recent Development
    Table 124. Tego Science Company Detail
    Table 125. Tego Science Business Overview
    Table 126. Tego Science Neurology Clinical Trial Product
    Table 127. Tego Science Revenue in Neurology Clinical Trial Business (2019-2024) & (US$ Million)
    Table 128. Tego Science Recent Development
    Table 129. Autolus therapeutics Company Detail
    Table 130. Autolus therapeutics Business Overview
    Table 131. Autolus therapeutics Neurology Clinical Trial Product
    Table 132. Autolus therapeutics Revenue in Neurology Clinical Trial Business (2019-2024) & (US$ Million)
    Table 133. Autolus therapeutics Recent Development
    Table 134. Bayer AG Company Detail
    Table 135. Bayer AG Business Overview
    Table 136. Bayer AG Neurology Clinical Trial Product
    Table 137. Bayer AG Revenue in Neurology Clinical Trial Business (2019-2024) & (US$ Million)
    Table 138. Bayer AG Recent Development
    Table 139. Sartorius AG Company Detail
    Table 140. Sartorius AG Business Overview
    Table 141. Sartorius AG Neurology Clinical Trial Product
    Table 142. Sartorius AG Revenue in Neurology Clinical Trial Business (2019-2024) & (US$ Million)
    Table 143. Sartorius AG Recent Development
    Table 144. Daiichi Sankyo Company Detail
    Table 145. Daiichi Sankyo Business Overview
    Table 146. Daiichi Sankyo Neurology Clinical Trial Product
    Table 147. Daiichi Sankyo Revenue in Neurology Clinical Trial Business (2019-2024) & (US$ Million)
    Table 148. Daiichi Sankyo Recent Development
    Table 149. Takeda Pharmaceutical Company Company Detail
    Table 150. Takeda Pharmaceutical Company Business Overview
    Table 151. Takeda Pharmaceutical Company Neurology Clinical Trial Product
    Table 152. Takeda Pharmaceutical Company Revenue in Neurology Clinical Trial Business (2019-2024) & (US$ Million)
    Table 153. Takeda Pharmaceutical Company Recent Development
    Table 154. Sumitomo Chemical Co Company Detail
    Table 155. Sumitomo Chemical Co Business Overview
    Table 156. Sumitomo Chemical Co Neurology Clinical Trial Product
    Table 157. Sumitomo Chemical Co Revenue in Neurology Clinical Trial Business (2019-2024) & (US$ Million)
    Table 158. Sumitomo Chemical Co Recent Development
    Table 159. Research Programs/Design for This Report
    Table 160. Key Data Information from Secondary Sources
    Table 161. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Neurology Clinical Trial Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Neurology Clinical Trial Market Share by Type: 2023 VS 2030
    Figure 3. Bone Marrow Features
    Figure 4. Epidermis Features
    Figure 5. Mesenchymal Stem Cells Features
    Figure 6. Haematopoietic Stem Cells Features
    Figure 7. Chondrocytes Features
    Figure 8. Global Neurology Clinical Trial Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Neurology Clinical Trial Market Share by Application: 2023 VS 2030
    Figure 10. Neurodegenerative Disorders Case Studies
    Figure 11. Cardiovascular Disorders Case Studies
    Figure 12. Orthopedics Case Studies
    Figure 13. Wound Healing Case Studies
    Figure 14. Other Case Studies
    Figure 15. Neurology Clinical Trial Report Years Considered
    Figure 16. Global Neurology Clinical Trial Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 17. Global Neurology Clinical Trial Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 18. Global Neurology Clinical Trial Market Share by Region: 2023 VS 2030
    Figure 19. Global Neurology Clinical Trial Market Share by Players in 2023
    Figure 20. Global Top Neurology Clinical Trial Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurology Clinical Trial as of 2023)
    Figure 21. The Top 10 and 5 Players Market Share by Neurology Clinical Trial Revenue in 2023
    Figure 22. North America Neurology Clinical Trial Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. North America Neurology Clinical Trial Market Share by Country (2019-2030)
    Figure 24. United States Neurology Clinical Trial Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Canada Neurology Clinical Trial Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Neurology Clinical Trial Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Europe Neurology Clinical Trial Market Share by Country (2019-2030)
    Figure 28. Germany Neurology Clinical Trial Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Neurology Clinical Trial Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Neurology Clinical Trial Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Neurology Clinical Trial Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Neurology Clinical Trial Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Neurology Clinical Trial Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Asia-Pacific Neurology Clinical Trial Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Asia-Pacific Neurology Clinical Trial Market Share by Region (2019-2030)
    Figure 36. China Neurology Clinical Trial Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Japan Neurology Clinical Trial Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. South Korea Neurology Clinical Trial Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Southeast Asia Neurology Clinical Trial Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. India Neurology Clinical Trial Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Australia Neurology Clinical Trial Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Latin America Neurology Clinical Trial Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Latin America Neurology Clinical Trial Market Share by Country (2019-2030)
    Figure 44. Mexico Neurology Clinical Trial Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Brazil Neurology Clinical Trial Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Middle East & Africa Neurology Clinical Trial Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East & Africa Neurology Clinical Trial Market Share by Country (2019-2030)
    Figure 48. Turkey Neurology Clinical Trial Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Saudi Arabia Neurology Clinical Trial Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. BrainStorm Cell Therapeutics Revenue Growth Rate in Neurology Clinical Trial Business (2019-2024)
    Figure 51. Opexa Therapeutics Revenue Growth Rate in Neurology Clinical Trial Business (2019-2024)
    Figure 52. Caladrius Biosciences Revenue Growth Rate in Neurology Clinical Trial Business (2019-2024)
    Figure 53. U.S. Stem Cell Revenue Growth Rate in Neurology Clinical Trial Business (2019-2024)
    Figure 54. Lonza Revenue Growth Rate in Neurology Clinical Trial Business (2019-2024)
    Figure 55. Bristol Myers Squibb Revenue Growth Rate in Neurology Clinical Trial Business (2019-2024)
    Figure 56. Corning Incorporated Revenue Growth Rate in Neurology Clinical Trial Business (2019-2024)
    Figure 57. Vericel Corporation Revenue Growth Rate in Neurology Clinical Trial Business (2019-2024)
    Figure 58. Catalent Revenue Growth Rate in Neurology Clinical Trial Business (2019-2024)
    Figure 59. Lineage Cell Therapeutics Revenue Growth Rate in Neurology Clinical Trial Business (2019-2024)
    Figure 60. Castle Creek Biosciences Revenue Growth Rate in Neurology Clinical Trial Business (2019-2024)
    Figure 61. Sangamo Therapeutics Revenue Growth Rate in Neurology Clinical Trial Business (2019-2024)
    Figure 62. Novartis Revenue Growth Rate in Neurology Clinical Trial Business (2019-2024)
    Figure 63. Holostem Terapie Avanzate S.R.L Revenue Growth Rate in Neurology Clinical Trial Business (2019-2024)
    Figure 64. Pharmicell Revenue Growth Rate in Neurology Clinical Trial Business (2019-2024)
    Figure 65. Tego Science Revenue Growth Rate in Neurology Clinical Trial Business (2019-2024)
    Figure 66. Autolus therapeutics Revenue Growth Rate in Neurology Clinical Trial Business (2019-2024)
    Figure 67. Bayer AG Revenue Growth Rate in Neurology Clinical Trial Business (2019-2024)
    Figure 68. Sartorius AG Revenue Growth Rate in Neurology Clinical Trial Business (2019-2024)
    Figure 69. Daiichi Sankyo Revenue Growth Rate in Neurology Clinical Trial Business (2019-2024)
    Figure 70. Takeda Pharmaceutical Company Revenue Growth Rate in Neurology Clinical Trial Business (2019-2024)
    Figure 71. Sumitomo Chemical Co Revenue Growth Rate in Neurology Clinical Trial Business (2019-2024)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Digital Health In Neurology Market Research Report 2024
Neurology Medical Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Neuro Critical Care Market Research Report 2024
Global Pediatric Clinical Trials Market Research Report 2024
Global Neurologic Disorder Treatment Drug Market Research Report 2024
Global Patient Recruitment for Clinical Trials Market Research Report 2025
Ophthalmic Clinical Trial Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Neurology Digital Therapeutics Market
Global Clinical Trial and Analysis Services Market Research Report 2024
Global Clinical Trial Recruitment and Management Services Market Research Report 2025
Global Clinical Trial Patient Recruitment Services Market Research Report 2025
Global HIV Clinical Trials Market Research Report 2025
Global Clinical Examination Market Research Report 2024
Global Clinical Research Digitization Market Research Report 2024
Clinical EHR Market
Global Infectious Disease Clinical Trials Market Research Report 2025
Global Neuroregeneration Therapy Market Research Report 2024
Global HIV and AIDS Clinical Trials Market Research Report 2025
Clinical Trial Kits Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
AI Assisted Diagnosis in Neurology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Neonatal Stem Cell Storage Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-38Q16325
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Stem Cell Research Antibodies Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35K16574
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Regenerative Biological Patch Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15B16632
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Umbilical Cord Mesenchymal Stem Cell Storage Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11R16792
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions